Ausgabe 3/2020
Inhalt (13 Artikel)
Clinical relevance of esophageal subepithelial activity in eosinophilic esophagitis
Ikuo Hirano
Patients with dyspepsia have impaired mucosal integrity both in the duodenum and jejunum: in vivo assessment of small bowel mucosal integrity using baseline impedance
Kenichiro Nakagawa, Ken Hara, Asma Fikree, Shahab Siddiqi, Philip Woodland, Atsushi Masamune, Qasim Aziz, Daniel Sifrim, Etsuro Yazaki
Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Chiaki Kusumoto, Takayuki Imada, Fumihiro Hamada, Tomowo Yoshida, Kenji Yokota, Toshiharu Mitsuhashi, Hiroyuki Okada
Correction to: Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Chiaki Kusumoto, Takayuki Imada, Fumihiro Hamada, Tomowo Yoshida, Kenji Yokota, Toshiharu Mitsuhashi, Hiroyuki Okada
Effects of vedolizumab in Japanese patients with Crohn’s disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses
Kenji Watanabe, Satoshi Motoya, Haruhiko Ogata, Takanori Kanai, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Kenkichi Sugiura, Kazunori Oda, Tetsuharu Hori, Takahiro Araki, Mamoru Watanabe, Toshifumi Hibi
Abdominal obesity increases risk for esophageal cancer: a nationwide population-based cohort study of South Korea
Jae Ho Cho, Cheol Min Shin, Kyung-Do Han, Hyuk Yoon, Young Soo Park, Nayoung Kim, Dong Ho Lee
The protective effect of betacellulin against acute pancreatitis is ERBB4 dependent
Kathrin Hedegger, Franziska Stumpf, Helmut Blum, Alexander Graf, Roland Michael Schmid, Marina Lesina, Hana Algül, Marlon Roberto Schneider, Maik Dahlhoff
Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis
Donghee Kim, Won Kim, Sae Kyung Joo, Jimin Han, Jung Ho Kim, Stephen A. Harrison, Zobair M. Younossi, Aijaz Ahmed
Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesilate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial
Morihisa Hirota, Tooru Shimosegawa, Katsuya Kitamura, Kazunori Takeda, Yoshifumi Takeyama, Toshihiko Mayumi, Tetsuhide Ito, Mamoru Takenaka, Eisuke Iwasaki, Hirotaka Sawano, Etsuji Ishida, Shin Miura, Atsushi Masamune, Yousuke Nakai, Akira Mitoro, Hiroyuki Maguchi, Kenji Kimura, Tsuyoshi Sanuki, Tetsuya Ito, Hiroki Haradome, Kazuto Kozaka, Toshifumi Gabata, Keisho Kataoka, Masahiko Hirota, Shuji Isaji, Ryoji Nakamura, Koki Yamagiwa, Chie Kayaba, Koji Ikeda
Transition in the etiology of liver cirrhosis in Japan: a nationwide survey
Hirayuki Enomoto, Yoshiyuki Ueno, Yoichi Hiasa, Hiroki Nishikawa, Shuhei Hige, Yasuhiro Takikawa, Makiko Taniai, Toru Ishikawa, Kohichiroh Yasui, Akinobu Takaki, Koichi Takaguchi, Akio Ido, Masayuki Kurosaki, Tatsuya Kanto, Shuhei Nishiguchi
Is metabolic syndrome responsible for the progression from NAFLD to NASH in non-obese patients?
Takumi Kawaguchi, Takuji Torimura